News | Computed Tomography (CT) | September 21, 2026

New FDA clearance brings a2z’s abdomen-pelvis CT triage portfolio to 17 findings across two devices.

a2z Radiology AI Expands Abdomen-Pelvis CT Triage Portfolio

Sept. 21, 2026 — a2z Radiology AI has announced FDA clearance of a2z-Abdo-Triage for 10 findings on abdomen-pelvis CT. This expands the range of suspected findings the company's software can flag for clinical review, building on the seven findings previously cleared for a2z-Unified-Triage.

“Care teams need support that reflects the range of cases they see,” said Samir Rajpurkar, co-founder and CEO of a2z Radiology AI. “We’re building a platform around that need. This clearance extends the range of clinically important findings we can flag on CT scans, bringing us closer to our goal of helping teams focus their attention where it is needed.”

The new software analyzes abdominopelvic CT images acquired with or without intravenous contrast in adults aged 22 and older. It flags and communicates suspected positive cases to help radiology teams prioritize studies for review. It works alongside standard image interpretation, with radiologists continuing to review the full scan and make clinical judgments. a2z-Abdo-Triage has also received FDA Breakthrough Device designation.

The ten newly cleared findings are obstructing ureteral stone, hydroureter, retroperitoneal hematoma, large volume ascites, acute appendicitis, intraabdominopelvic abscess, hemoperitoneum or complex free fluid, splenic traumatic injury, hepatic traumatic injury and renal traumatic injury.

The seven previously cleared findings are acute cholecystitis, acute pancreatitis, unruptured abdominal aortic aneurysm, acute diverticulitis, free air, hydronephrosis and small bowel obstruction.

a2z’s goal is to turn broader imaging coverage into more useful support for care teams and, ultimately, timely attention for the patients who need it.

 

a2z Abdomen pelvis

 


Additional Content

News | Lung Imaging

Nov.2, 2026 – SimonMed has announced the clinical launch of two advanced lung imaging technologies, CT:VQ and LDAf, in ...

Time November 02, 2026
arrow
News | Radiology Imaging

Oct. 19, 2026 — Paradromics Inc. has announced a collaboration with Siemens Healthineers to develop an advanced ...

Time October 26, 2026
arrow
News | Women's Health

Oct. 15, 2026— SimBioSys has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of TumorSight Risk, its ...

Time October 19, 2026
arrow
News | Information Technology

October 6, 2026 – Clearsense has introduced a cloud-based medical image archive designed to reduce the cost of ...

Time October 07, 2026
arrow
News | Pediatric Imaging

Sept. 29, 2026 — Visiana has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for ...

Time October 02, 2026
arrow
Subscribe Now